CAS NO: | 13171-25-0 |
规格: | ≥98% |
包装 | 价格(元) |
5mg | 电议 |
50mg | 电议 |
500mg | 电议 |
Trimetazidine Dihydrochloride is a fatty acid oxidation inhibitor as an anti-ischemic (anti-anginal) metabolic agent, improving myocardial glucose utilization through inhibition of fatty acid metabolism and and preventing macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin. References: Su Q, Li L, Zhao J, Sun Y, Yang H. Effects of trimetazidine on periprocedural microRNA-21 expression by CD4+ T lymphocytes in patients with unstable angina pectoris. Oncotarget. 2017 Sep 18;8(62):104992-104999. doi: 10.18632/oncotarget.20975. eCollection 2017 Dec 1. PubMed PMID: 29285227; PubMed Central PMCID: PMC5739614.
纯度:≥98%
CAS:13171-25-0